1)cannabinoid receptor大麻素受体
1.No changes in densities of cannabinoid receptors in the superior temporal gyrus in schizophrenia;精神分裂症患者颞上回的大麻素受体密度没有显著性变化(英文)
2.Anandamide(AEA),one of the main endocannabinoids,activates both cannabinoid receptors(CBR) and transient potential vanilloid receptor type-1(TRPV1),which exerts wide and complicated biological effects.花生四烯酸乙醇胺(AEA)是一种内源性大麻素样物质,可与大麻素受体(CBR)和辣椒素受体(TR-PV1)结合而发挥广泛复杂的生物学效应。
3.Objective To explore the protective effects of WIN55212-2,an agonist of cannabinoid receptor,on ischemia-reperfusion injury in isolated rat hearts.目的探讨大麻素受体激动剂WIN55212-2对体外大鼠心肌缺血再灌注损伤的保护作用。
英文短句/例句
1.Recently drugs that act on cannabinoid receptors- the ones that mediate marijuana's effects- have been advancing through clinical trials.最近,作用于大麻素受体的药物也进入了临床试验;大麻素受体是大麻在人体内作用的位置。
2.Studies on the Design, Synthesis of CB1 Receptor Antagonists;大麻素受体Ⅰ型抑制剂的设计与合成
3.Distributions of CB1 and CB2-positive cells in adult rat′s brain大麻素受体在成年大鼠脑组织中的分布特点
4.Studies on Synthesis of Rimonabant;新的大麻素受体拮抗剂利莫那班的合成
5.Effects of Glucocorticoids on Bone Mass, Bone Microarchitecture and the Expression of Cannabinoid Receptor 1 in Rats;糖皮质激素对大鼠骨量、骨微结构和大麻素受体1表达的影响研究
6.Effects of Cannabinoid-1 receptor on the intestinal myoelectric disturbance induced by lipopolysaccharide in rat大麻素受体-1对内毒素诱导的大鼠小肠肌电活动的影响
7.Experimental Study of Cannabinoid Receptor 2 in Titanium Particle Induced Osteolysis大麻素受体CB2在钛颗粒诱导假体周围骨溶解中作用的实验研究
8.The Studies on the Brain Protection Induced by Cannabinoid Receptor Agonist WIN 55, 212-2 Preconditioning and Its Mechanism in Rats;大麻素受体激动剂预处理脑保护作用及机制的研究
9.The Preclinical Toxicology and Toxicity Mechanisms of MJ15, a New Cannabinoid Receptor Antagonist Weight-Reducing Drug;新型大麻素受体拮抗剂类减肥药MJ15临床前毒理学及相关机制研究
10.Cannabinoid Receptor 1 Gene Polymorphism and Irritable Bowel Syndrome大麻素受体1基因多态性和肠易激综合征的关系
11.The Study of Cannabinoid CB1 Receptor Expressed in the Hippocampus of Streptozotocin-induced Diabetic Rats;大麻素1型受体在糖尿病大鼠海马表达的研究
12.Study on the Angiogenesis Mechanism of Cannabinoid Receptor Ⅱ Agonist in Malignant Melanoma大麻素Ⅱ型受体激动剂在恶性黑素瘤中血管生成作用机制的研究
13.Distribution and Expression Pattern of Cannabinoid Receptors CB1 and CB2 in Brain of SD Rats大麻素CB1、CB2受体在脑组织中分布及其表达特性的研究
14.Distribution of cannabinoid receptor 2 expression in sarcoidosis and granuloma annulare tissues大麻素Ⅱ型受体在结节病、环状肉芽肿中的组织分布
15.The CB2 Cannabinoid Receptor-mediated Antinociception and Its Expression in Rats with Neuropathic Pain;神经病理性疼痛大鼠大麻素Ⅱ型受体介导的抗伤害作用及受体表达的研究
16.Analysis of the Interaction of Measles Virus Hemagglutinin Protein with Its Receptors and Their Roles in MV Infection麻疹病毒血凝素蛋白与受体的相互作用及麻疹病毒侵染机制研究
17.Role of Cannabinoid CB1 Receptor Antagonist Rimonabant in Methamphetamine Conditioned Place Preference in Mice;大麻素CB1受体拮抗剂利莫那班对小鼠甲基苯丙胺条件性位置偏爱的影响
18.Effects of Gastrodin on Expressions of mGluR1 and PKCαin Hippocampus of Rats with Seizures Induced by Pentylenetetrazole天麻素对戊四氮致癎大鼠海马代谢型谷氨酸受体1和蛋白激酶Cα表达的影响
相关短句/例句
Cannabinoid receptors大麻素受体
1.Anandamide (N arachidonoylethanolamide), an arachidonic acid derivative, is an endogenous ligand for cannabinoid receptors, which are members of the G protein (Gi) coupled receptors family.花生四烯乙醇胺 (arachidonoylethanolamide,anandamide ,ANA)是近年来确定的大麻素受体的内源性配基 ,它主要分布在中枢神经系统、免疫系统及子宫等部位 ,具有大麻的主要活性成分———Δ9 四氢大麻酚 (Δ9 THC)的药理功能 。
3)canabinoid CB1 receptor大麻素CB1受体
4)cannabinoid receptor 1大麻素受体1
1.Advances in cannabinoid receptor 1 antagonistic effect in obesity;大麻素受体1阻断剂在治疗肥胖症中的作用
2.Aim:To investigate the expression pattern of cannabinoid receptor 1(CBR_1) in the basal ganglia of a 6-OHDA unilaterally injured Parkinson s disease(PD) rat model,and to explore the relationship between PD and the change of expression pattern of CBR_1 in the basal ganglia.目的:观察6-OHDA单侧毁损帕金森病(PD)大鼠模型基底节内大麻素受体1(CBR_1)表达特点,探讨其与PD的关系。
5)Cannabinoid CB1 Receptor大麻素1型受体
1.The Study of Cannabinoid CB1 Receptor Expressed in the Hippocampus of Streptozotocin-induced Diabetic Rats;大麻素1型受体在糖尿病大鼠海马表达的研究
6)CB1大麻素受体CB1
延伸阅读
紫杉醇 ,紫素,特素,紫烷素,路泰,泰素药物名称:红豆杉醇英文名:Taxol别名: 红豆杉醇;紫杉醇 ,紫素,特素,紫烷素,路泰,泰素 外文名:Taxol ,TAX,Paclitaxel,PTX适应症: 本品适用于一线或其后的卵巢转移性癌化疗失败以后的治疗。 用量用法: 稀释的泰素注射液应先经过所连接的直径不超过0.22μm孔膜的滤过装置,使用前先用地噻米松、苯海拉明及H2一受体拮抗剂。 注意事项: 1.可有白细胞、血小板减少、贫血(血色素减少)、感染、粘膜炎、出血、过敏反应、低血压、心动过缓、心电图异常、关节痛、肌肉痛、转氨酶和胆红素升高、脱发、恶心及呕吐。 2.对本品有过敏者及骨髓抑制患者忌用。 规格: 浓缩注射液:30mg/支。 类别:抗肿瘤植物成分药
